» Articles » PMID: 11122245

Characterization of the T Cell Recognition of Hepatitis B Surface Antigen (HBsAg) by Good and Poor Responders to Hepatitis B Vaccines

Overview
Date 2000 Dec 21
PMID 11122245
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

To study the regulation of the human cellular immune response to HBsAg we produced a series of HBsAg-specific T cell lines from good and poor responders to the hepatitis B vaccine. All T cell lines expressed CD4 on their membrane and could therefore be considered of the helper/inducer phenotype. The different HBsAg-specific T cell lines were restricted by HLA-DRB5*0101, DRB1*1201, -DRB1*0701, -DRB1*0301, -DPB1*0201, -DPB1*0402, and -DPB1*0901. In good responders to the hepatitis B vaccine different HLA molecules could act as restricting element. In poor responders the diversity of HLA class II restriction determinants was more limited. This leads us to conclude that the immune response to HBsAg is multispecific and polyclonal in good responders and paucispecific and oligoclonal in poor responders to the hepatitis B vaccine. By using a panel of synthetic peptides representing selected sequences of the HBsAg, the fine specificities of each of these T cell lines could be determined. Strikingly, the majority of the identified T cell epitopes was located in and around the first hydrophobic transmembranous region of the HBsAg. This was observed in T cell lines from good and poor vaccine responders, without distinction. The remarkable T cell immunogenicity of this region may reside in its richness in binding motifs for a variety of HLA class II determinants.

Citing Articles

HBV Vaccines: Advances and Development.

Mahmood F, Xu R, Awan M, Song Y, Han Q, Xia X Vaccines (Basel). 2023; 11(12).

PMID: 38140265 PMC: 10747071. DOI: 10.3390/vaccines11121862.


High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection.

Wang T, Shen C, Li H, Chen L, Liu S, Qi J BMC Immunol. 2022; 23(1):22.

PMID: 35468727 PMC: 9040378. DOI: 10.1186/s12865-022-00496-2.


A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus.

Wu Y, Ding Y, Shen C Vaccines (Basel). 2022; 10(2).

PMID: 35214714 PMC: 8878595. DOI: 10.3390/vaccines10020257.


Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders.

Yang J, Li Y, Ye J, Wang J, Lu H, Yao X J Inflamm Res. 2022; 15:939-951.

PMID: 35210805 PMC: 8856041. DOI: 10.2147/JIR.S347702.


Therapeutic vaccination for treatment of chronic hepatitis B.

Cargill T, Barnes E Clin Exp Immunol. 2021; 205(2):106-118.

PMID: 33969474 PMC: 8274149. DOI: 10.1111/cei.13614.


References
1.
McDermott A, Madrigal J, Sabin C, Zuckerman J, Cohen S . The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination. Vaccine. 1999; 17(11-12):1329-37. DOI: 10.1016/s0264-410x(98)00389-2. View

2.
Rahman F, Dahmen A, Herzog-Hauff S, Bocher W, Galle P, Lohr H . Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology. 2000; 31(2):521-7. DOI: 10.1002/hep.510310237. View

3.
Roberts I, Bernard C, VYAS G, Mackay I . T-cell dependence of immune response to hepatitis B antigen in mice. Nature. 1975; 254(5501):606-7. DOI: 10.1038/254606a0. View

4.
Kropshofer H, Max H, Muller C, Hesse F, Stevanovic S, Jung G . Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med. 1992; 175(6):1799-803. PMC: 2119237. DOI: 10.1084/jem.175.6.1799. View

5.
Manivel V, Ramesh R, Panda S, Rao K . A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of hepatitis B surface antigen. J Immunol. 1992; 148(12):4006-11. View